Introduction
The eCB system is involved in many functions of the CNS, including executive functions associated with the prefrontal cortex, such as decision-making and working memory (Pattij et al. 2008) . The eCB system consists of at least two G-protein coupled receptors (GPCR), CB 1 R and CB 2 R, lipid endogenous ligands (e.g. anandamide and 2-arachidonoylglycerol) and various enzymes responsible for the synthesis and degradation of the endogenous ligands (Devane et al. 1992; Mechoulam et al. 1995; Bracey et al. 2002; Dinh et al. 2002; Kano et al. 2009 ). CB 1 R are one of the most abundantly expressed GPCR in the rat brain and their role, predominantly as presynaptic receptors, in modulating neurotransmission is clearly established (Herkenham et al. 1991; Wilson and Nicoll 2001; Kano et al. 2009 ).
In contrast with CB 1 R, the presence and function of CB 2 R in the brain has long been a matter of debate (Atwood and Mackie 2010) . CB 2 R are found primarily in the immune system and were initially regarded as the 'peripheral' cannabinoid receptor (Munro et al. 1993; Galiègue et al. 1995) . This generally accepted idea is challenged by the description of CNS CB 2 R gene expression in rats and wild-type mice (Gong et al. 2006; Liu et al. 2009; García-Gutiérrez et al. 2010 ) and the identification of functional CB 2 R receptors on glial cells and neurons (Carlisle et al. 2002; Van Sickle et al. 2005; Onaivi et al. 2006; Stella 2010) . In addition to the current view that supports the expression of functional CB 2 R in neurons upon brain stress or damage (Viscomi et al. 2009 ), it has been reported that CB 2 R could play a role in general CNS physiology (Elmes et al. 2004; Morgan et al. 2009; Xi et al. 2011) . These developments emphasize the importance of understanding how CB 2 R activation affects neuronal functioning. To demonstrate the presence of functional CB 2 R in the rodent mPFC and to elucidate their functional role we used Western blotting, a radioactive binding assay and electrophysiological techniques (whole-cell current and voltage clamp) on layer II/III pyramidal neurons.
Materials and Methods

Western Blotting
Experiments were approved by the animal welfare committee of the University of Amsterdam. mPFC, brain stem, spleen and skeletal muscle of 14-day old male Wistar rats (Harlan, The Netherlands) were rapidly dissected out in ice-cold homogenization buffer (0.05 mM phosphate buffered saline (PBS)) with 320 mM sucrose and protease inhibitor mixture (Complete, Roche, pH 7.4) and homogenized with a glass douncer. For subcellular fractionation of the mPFC the same buffer was used. The homogenate was centrifuged at 800 x g for 10 minutes to discard undisrupted tissue. The supernatant was centrifuged at 100000 x g for 1 hr to separate plasma membrane fractions (pellet) from intracellular fractions (supernatant). Equal amounts of protein, 10 or 20 µg, were loaded and separated by 10% SDS-PAGE and transferred onto nitrocellulose membrane. The membranes were washed in 10% Tris buffered saline (TBS) and blocked in TBS with 1% Tween (TBST) containing 4% non-fat milk and incubated overnight at 4 °C with antibodies against CB 2 R (Abcam, 1:800) alone or in combination with antibodies against 49 the plasma membrane marker Na + /K + -ATPase α3 (Santa Cruz, 1:500) and against the nuclear envelope marker nucleoporin p62 (Beckton Dickinson, 1:800). In some cases the CB 2 R antibody was preincubated with the immunogen peptide (Abcam, 1:40) . Membranes were washed with TBST and incubated for 1 h with HRP-conjugated goat anti-rabbit antibody (Bio-Rad, 1:3000), goat anti-mouse antibody (Bio-Rad, 1:3000) and donkey anti-goat antibody (Santa Cruz, 1:5000) and processed for immunoreactivities using enhanced chemiluminesence (ECL) Plus Western Blotting detection reagents (Amersham, USA). Bands were visualized with Hyperfilm ECl (Amersham) or the Odyssey Infrared Imaging System (Licor, USA).
Radioactive binding assay
CB 1 R and CB 2 R binding was assessed by rapid filtration assays, using 400 pM [ 3 H]CP55.940 as reported (Maccarrone et al. 2008) . mPFC tissue of 14-day old male Wistar rats (Harlan, The Netherlands) was used in rapid filtration assays, after subcellular fractionation as described for the Western blot samples in 2 mM Tris-EDTA, 320 mM sucrose, 5 mM MgCl 2 (pH 7.4). Unspecific binding was determined in the presence of "cold" agonist (1 µM CP55.940), and was further corroborated by selective antagonists (0.1 µM SR141716 (SR1) for CB 1 R, or 0.1 µM SR144528 (SR2) for CB 2 R). Binding data were expressed as fmol ligand bound per mg of protein.
Electrophysiology
Coronal slices (300 µm) of the mPFC were obtained from male Wistar rats (Harlan, The Netherlands) aged 14-19 days postnatal and male C57BL/6 Wt mice or male C57BL/6 CB 2 R KO mice (The Jackson Laboratory, USA) aged 14-19 days postnatal. Animals were killed by decapitation, their brains rapidly removed and placed in oxygenated (95% O 2 -5% CO 2 ) ice cold (4 °C) adapted artificial cerebrospinal fluid (aaCSF, containing in mM: 120 choline chloride, 3.5 KCl, 0.5 CaCl 2 , 6 MgSO 4 , 1.25 NaH 2 PO 4 , 25 D-glucose, 25 NaHCO 3 ). Slices were cut in aaCSF on a vibratome (VT1200S, Leica, Germany) and placed for 30 min in aCSF (containing in mM: 120 NaCl, 3. In the whole-cell current clamp configuration, we used a slow feedback system that guaranteed that current clamp recordings started at a membrane voltage of -80 mV ( Fig. 1 and 3 ) or -70 mV (Fig. 4) evoked from a holding potential of -50 mV. Input resistance was calculated from current responses to hyperpolarizing steps of -5 mV. Frozen filtered Gaussian noise (time constant = 10 ms) was injected via the patch pipette with a variance adjusted for each neuron to result in a mean spike frequency (~0.85 Hz). The firing frequency was calculated using 1-min bins. Prior to drug application (or at least 10 min after preincubation with Sch.356036), 5-min recordings were used as control. Drug effects were determined 3-15 min after application. Recordings were made using an EPC9 patch-clamp amplifier controlled by PULSE software (HEKA Electronic GmbH, Germany) and in-house software running under Matlab (MathWorks, USA). Signals were filtered at 2.9 kHz and sampled at 10 kHz. Series resistance ranged from 5-15 MΩ and was compensated to ~65%. Signals were corrected for liquid junction potential. Current densities were calculated using cell capacitance and expressed in pA/pF.
Data analysis
Data were statistically tested with t-tests unless otherwise stated. In the figures the significance is indicated with asterisks (*P<0.05, ** P<0.01 and *** P<0.001).
Drugs
For the radioactive binding assay, the synthetic cannabinoid CP55. 
Results
Functional CB2R in the mPFC
The presence of CB 2 R in the rat mPFC was demonstrated by a Western blot performed on homogenated mPFC samples (Fig. 1A) . A band of the expected molecular weight for 51 CB 2 R was detected, which was absent when the primary antibody was incubated with immunizing peptide (Fig. 1A) . Immunoblots on tissues from spleen and brainstem (positive controls) and skeletal muscle tissue (negative controls) confirmed the specificity of the CB 2 R immuno detection (Fig. 1A) .
To investigate whether CB 2 R activation can modulate ion conductances, we performed whole-cell current clamp recordings in layer II/III pyramidal neurons of the mPFC at an experimental membrane potential (Vm = -80 mV) that differed from all experimental ion equilibrium potentials. We observed that bath applications of the selective CB 2 R agonist JWH-133 (1 µM and 5 µM) resulted in a transient depolarization in most (86%) layer II/III pyramidal neurons of the mPFC, after a delay that lasted several minutes (Fig. 1B-C) . The depolarization induced by bath application of 1 µM JWH-133 was significantly smaller after preincubation of the slice with a selective CB 2 R antagonist, Sch.356036 (5 µM) (Fig. 1C) . We confirmed the pharmacological evidence that the depolarization is mediated by CB 2 R activation by performing similar experiments in CB 2 R knock-out (KO) and wild type (Wt) mice. We did not observe a delayed depolarizing response in mPFC neurons from KO mice, whereas in Wt mice such responses could be evoked (Fig. 1C) .
To investigate the origin of the depolarization delay, we repeated the experiments but replaced the bath application by fast local pressure ejection of 5 µM JWH-133 onto the soma of patched layer II/III pyramidal neurons. As the depolarization delay was hardly affected (Fig. 1C-D) , we concluded that it did not originate from diffusion limitations in the bath application method. We hypothesised that CB 2 R are located intracellularly in these neurons and that the depolarization delay most likely originates from the time required for the lipophilic ligands to pass the plasma membrane and to reach the intracellularly located target. To test this, we introduced 5 µM JWH-133 into the cell via the patch pipette and we still observed a depolarization (Fig. 1C ), but with a much reduced delay (~1.5 min) after going whole-cell (Fig. 1D) . Introduction of the antagonist Sch.356036 (1 µM) into the cell via the patch pipette largely prevented the membrane depolarization induced by bath application of 1 µM JWH-133 (Fig. 1C) . When the antagonist Sch.356036 was bath applied, 5 µM was needed to antagonize the JWH-133 (1 µM) effect (Fig. 1C) . Taken together, the combined electrophysiological and pharmacological experiments suggest an intracellular localization of CB 2 R.
CB2R are intracellularly localized in the mPFC
To obtain further evidence for an intracellular localization for CB 2 R, we performed additional Western blot experiments. Whole mPFC samples were fractionated into a plasma membrane and an intracellular fraction. The identity of the fractions was established using antibodies against the plasma membrane marker Na + /K + -ATPase and the intracellular marker nucleoporin. The Western blot on fractionated samples showed that CB 2 R are abundantly present in the intracellular fraction, whereas they are hardly detectable in the plasma membrane fraction ( Fig. 2A) . Experiments using a radio-active binding assay on similarly fractionated mPFC samples corroborated the .940 (a mixed CB 1 R/CB 2 R agonist) was reduced by ~50% in the presence of the selective CB 2 R antagonist SR2 (SR144528), but not when the selective CB 1 R antagonist SR1 (SR141716) was present. Incubating the plasma membrane fraction with SR1 or SR2 reduced the binding of [ 3 H]CP55.940. However, this reduction in binding was much larger in the presence of SR1 (~70% reduction) than in the presence of SR2 (~20% reduction). These results confirm that CB 2 R binding sites are predominantly located intracellularly in the rat mPFC, while CB 1 R binding sites appear to be mainly present in the plasma membrane. In additional fluorescence imaging experiments on a neuronal cell line (human SH-SY5Y neuroblastoma cells transiently transfected with GFP-tagged CB 2 R), we demonstrated that CB 2 R are almost exclusively localized in intracellular membranous structures and that they are not present on the plasma membrane ( Fig. S1 and Table  S1 ). The signalling cascade following CB 2 R activation can lead, through phospolipase C production, to Ca 2+ release via IP 3 Rs (Zoratti et al. 2003 ) and thus to the potential activation of Ca 2+ -activated conductance (Frings et al. 2000) . Introduction of the fast Ca 2+ chelator 1,2-Bis(2-Aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA) at a high concentration (10 mM) into the cell via the patch pipette, strongly reduced the amplitude of the delayed depolarization (Fig. 3A) . Bath application of the IP 3 R blocker 2-aminoethyl diphenylborinate (2-APB, 0.1 mM) also reduced indicate that a rise in [Ca 2+ ] i following IP 3 R activation is necessary for the CB 2 R-mediated depolarization. A series of voltage clamp experiments was performed to determine which conductance underlies the CB 2 R-mediated depolarization. Application of JWH-133 (1 µM) decreased the input resistance (R input ; Fig. 3B ), implying that the signal transduction pathway following CB 2 R activation opens ion channels in the plasma membrane. Using a series of step potentials before and during this JWH-133 application allowed the construction of a current-voltage (I/V) relationship that reversed near the calculated reversal potential (E rev ) for Cl -(E Cl-) (Fig. 3C) . Blocking K + , Ca 2+ , and Na + channels with 4-aminopyridine (4-AP), tetraethylammonium-Cl (TEACl), Cd 2+ and tetrodotoxin (TTX), hardly had an effect on the magnitude and the reversal potential of the currents evoked by JWH-133 (Fig. 3D ). In addition, decreasing [Cl -] i to 4.95 mM shifted E rev towards the newly established E Cl- (Fig. 3D ). We observed similar currents when we used a different selective CB 2 R agonist, HU-308 (1 µM) (Fig. 3D, inset) . Finally, the JWH-133-evoked currents were markedly reduced in the presence of the Cl -channel blocker 4,4′-Diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS) (Fig. 3E) . In summary, these results show that CB 2 R activation leads to the opening of Ca 2+ -activated Cl -channels (CaCCs), that may contribute to the control of the membrane potential of layer II/III pyramidal neurons of the rat mPFC.
CB2R activation reduces neuronal excitability
The hypothesis that the CB 2 R-mediated signalling pathway contributes to neuronal excitability was further investigated in a series of current clamp experiments under physiological Cl -conditions (E Cl-= -70 mV). A 'slow' automatic feedback system ensured that recordings always started at a membrane potential of -70 mV. Neuronal firing was evoked by Gaussian current input into the soma, via the patch pipette, that evoked fluctuations around resting membrane potential. For each neuron, the variance of the input signal was adjusted to cause a stable spiking rate (around 0.85 Hz). Application of 1 µM JWH-133 reduced the firing rate by 45% and this reduction could be prevented by preincubation (of at least 10 min) with the CB 2 R antagonist, Sch.356036 (5 µM) (Fig. 4) .
In a separate experiment we tested the effect of Sch.356036 by itself on the firing rate. Application of 5 µM Sch.356036 increased the firing rate (mean baseline firing frequency of 0.86±0.09 Hz was normalized over slices to 100±8% and increased to 121±8% in the presence of Sch.356036, p < 0.05, n = 12) . These results indicate an endogenous tonus of eCBs and/or constitutive activity of the receptor and show that, when firing is evoked with an input that could resemble spontaneous background synaptic activity, further CB 2 R activation modulates the firing rate of mPFC neurons. 
Discussion
Our results provide the first evidence for functional neuronal CB 2 R that are located intracellularly, in the rodent mPFC. Their activation results, via IP 3 R activation, in the opening of CaCCs. Furthermore, this opening of CaCCs is most likely responsible for the observed reduction in neuronal excitability upon CB 2 R activation. The presence of CB 2 R mRNA in the brain and CB 2 R in neurons of the brainstem, the cerebellum and the hippocampus has been reported (Van Sickle et al. 2005; Gong et al. 2006; Brusco et al. 2008a Brusco et al. , 2008b Onaivi et al. 2008 Onaivi et al. , 2012 García-Gutiérrez et al. 2010 ), but their presence in the cortex remained to be further characterized. The current view on the presence of functional CB 2 R in the CNS supports the expression of CB 2 R in neurons essentially upon brain stress and damage (Viscomi et al. 2009 ). Commonplace problems with the visualization of CB 2 R by immunohistochemical stainings have been described. These problems may arise from the difficulty of producing reliable antibodies against CB 2 R, slight differences in diaminobenzidine (DAB) staining protocols, species-specific isoform expression patterns and complications with negative controls such as CB 2 R-KO (Liu et al. 2009; Atwood and Mackie 2010; Ashton 2012; Onaivi et al. 2012) . Therefore, we used a combination of biochemical (Western blotting and radio-active binding assay) and functional (in vitro electrophysiology and pharmacology) techniques to provide evidence that functional CB 2 R are expressed intracellularly in cortical neurons of the healthy brain. The results of the radio-active binding assay did not depend on the quality of antibodies and provided additional support for the intracellular presence of CB 2 R in the mPFC where this technique confirmed that CB 1 R are primarily located in the plasma membrane. In addition, by means of fluorescence imaging we could demonstrate that in a neuronal cell line (human neuroblastoma cells; see Supplemental Information) CB 2 R are predominantly located in intracellular membranous structures and not in the plasma membrane. In accordance with our results, a few publications support the idea that, like other functional GPCR (Lee et al. 2004a; Jong et al. 2005a) , functional CB 2 R may have an intracellular localization. A report by Currie et al. (Currie et al. 2008) shows the intracellular localization of functional CB 2 R in guinea pig heart cells. Others report that CB 2 R are associated with the rough endoplasmic reticulum and Golgi apparatus in hippocampal pyramidal neurons, but in these studies the functional role of intracellular CB 2 R was not investigated (Brusco et al. 2008a (Brusco et al. , 2008b Onaivi et al. 2012) . , CB 2 R activation was reported to be negatively coupled to IP 3 R-mediated Ca 2+ release. In addition to the known CB 2 R-mediated pathways, we demonstrate that in rodent layer II/III cortical pyramidal neurons, the CB 2 R signalling cascade involves IP 3 R activation and results in the opening of CaCCs. CaCCs are known to control excitability in various types of peripheral and central neurons (Frings et al. 2000; Hartzell et al. 2005 ), but have not been described before in pyramidal neurons of the mPFC. Although some publications report a functional role for CB 2 R in the CNS (Elmes et al. 2004; Morgan et al. 2009; Xi et al. 2011 ), the precise mode of action is not known.
In this study we demonstrate that CB 2 R activation -under physiological conditionsleads to a decrease in neuronal firing rate, probably via the opening of CaCCs. If E Cl-is close to the resting membrane potential of cortical neurons, the activation of CB 2 R will stabilize or even clamp the membrane potential around that level. This reduction of neuronal excitability upon CB 2 R activation is reminiscent of shunting inhibition, described for GABA A receptors (Andersen et al. 1980; Staley and Mody 1992) , that also mediate a Cl -conductance. Furthermore, we observed that the application of a CB 2 R antagonist slightly increased the firing rate, indicative of a certain eCB tonus and/or a constitutive activity of the receptor. These results are in line with both the emerging 58 idea that the eCB system consists of a basal and an "on demand" pool of endocannabinoids and with the possibility of constitutively active CB 2 R (Alger and Kim 2011; Di Marzo 2011; Atwood, Wager-Miller, et al. 2012) . The mode of action we report here could be the underlying mechanism involved in the reduction of firing activity by JWH-133 in wide-range dorsal horn neurons in a rat model of acute, inflammatory and neuropathic pain (Elmes et al. 2004 ) and in thalamic neurons in a rat model of neuropathic pain (Jhaveri et al. 2008) . The unique aspects of eCB signalling we describe in this study, uncover a novel modulatory role for the eCB system in mPFC function, through the regulation of neuronal excitability by CB 2 R activation. As high frequency stimulation leads to eCB synthesis (Brown et al. 2003) , activation of CB 2 R following increased neuronal activity may prevent excessive neuronal firing via an intracellularly organised feedback system. Through this mechanism CB 2 R could play a protective role in the brain (Pacher and Mechoulam 2011) . More generally, the differential (sub)cellular localization of CB 1 R and CB 2 R and their downstream pathways diversify the response repertoire of the neuronal eCB system beyond the generally accepted modulation of neurotransmission processes.
Supplemental information
Materials and Methods
Reagents. DiIC16 was purchased from Molecular Probes. Attractene was from QIAGEN. Culture media, sera, and supplements were from Euroclone. All other chemicals were purchased from Sigma Chemical, unless stated otherwise.
GFP Fusion Construct
To generate green fluorescent fusion protein, human CB 2 R was amplified and cloned in frame to a GFPtag in a pVL-GFP vector (AB Vector) (Oddi et al. 2011) .
Cell Culture and Transfection
Human SH-SY5Y neuroblastoma cells were grown in Roswell Park Memorial Institute (RPMI) 1640 medium, supplemented with 10% FBS, 2 mM glutamine, 1 mM sodium pyruvate, 100 Units/mL penicillin, and 50 Units/mL streptomycin, at 37 °C in a 5% CO 2 humidified atmosphere (Oddi et al. 2011) . A monolayer of native cells at 70-80% confluence in eight-well chamber slides (Ibidi) or in collagen-coated (20 μg/mL) coverslips (10 mm diameter) were transiently transfected with CB 2 R-GFP by using the Attractene reagent as suggested by the manufacturer (QIAGEN).
Imaging
A Leica TCS SP5 DMI6000 confocal microscope (Leica Microsystems) was equipped with Leica HCX plan apo 63× (numerical aperture 1.4) oil immersion objective. Excitation laser lines were 488 nm (argon laser) and 561 nm (diode pumped solid state laser). GFP-tagged CB 2 R was excited at 488 nm, and the corresponding fluorescence was detected by using a 525 ± 25 nm bandpass filter. DiIC16 was excited by using a 561-nm laser line, and the corresponding fluorescence was detected by using a 580-to 620-nm bandpass filter. In the codetection experiments of GFP and DiIC16, cells were fixed, and green fluorescence emission and red fluorescence emission were acquired sequentially upon excitation with 488-nm and 561-nm laser light, respectively. Pictures were taken by using the Leica Application Suite Advanced Fluorescence (LAS AF) software (Leica Microsystems). For presentation purposes, LAS AF pictures were exported in TIFF format and processed with Adobe Photoshop CS2, for adjustments of brightness and contrast. Quantification of the mean fluorescence intensity in selected regions was carried out by using the ImageJ software (http://rsb.info.nih.gov/ij/). For image analysis, five fields from at least three independent experiments were examined.
For assessing membrane targeting of GFP-tagged CB 2 R, we imaged transfected cells that were costained by extracellular application of the red emitting lipophilic dye DiIC16 (Oddi et al. 2011) . Briefly, transfected cells were washed three times with RPMI without phenol red, incubated with RPMI containing 4 μg/mL DiIC16 for 5 min on ice, rinsed twice with cold PBS, fixed with 2% formaldehyde in PBS, and examined by confocal fluorescence imaging. For quantification of the membrane/total (M/T) CB 2 R ratio, we measured mean fluorescence density values (M and T), 60 corresponding to the membrane (measured from the edge of the cell to 300 nm inside, M) and total cell area (surface plus cytoplasm, T), respectively. A more accurate estimate of the level of localization of GFP-tagged CB 2 R at the plasma membrane was obtained through the overlap coefficient, which measures the degree of overlap between green (Fig. S1A , GFP-tagged CB 2 R) and red (Fig. S1B, DiIC16) fluorescence (Marchant et al. 2002) . Overlap coefficients were measured by using the ImageJ plugin JACoP that groups together the most important colocalization tools (Bolte and Cordelières 2006) . Apparent colocalization due to random staining, or very high intensity, in one window will have values of overlap coefficient near to zero, whereas if the two signal intensities are interdependent (colocalized), these values will be positive with a maximum of 1. Fluorescence microscopy analysis of the subcellular localization of GFP-tagged CB 2 R in human neuroblastoma revealed that CB 2 R staining was almost completely intracellular, and was distributed in several dotted membranous structures that were widely diffused in the cytoplasm, with scarce or absent association to the plasma membrane (Fig. S1 ). The virtual exclusion of CB 2 R from the plasma membrane of SH-SY5Y cells was quantitatively assessed by the very low values (close to zero) of the overlap coefficient and the membrane/total (M/T) CB 2 R fluorescence ratio (Table S1 ).
It is noteworthy that the same analysis of the subcellular localization of GFPtagged CB 1 R in SH-SY5Y cells showed an overall expression of the receptor approximately twofold higher than that of GFP-CB 2 R on the cell surface (M/T ratio = 0.120 ±0.020) (1), but a quantitative colocalization with the plasma membrane marker DiIC16 that was ≈19-fold higher (overlap coefficient = 0.75 ± 0.04) (Oddi et al. 2012) . Taken together, these data clearly demonstrate that CB 2 Rs are much less associated with the plasma membrane than CB 1 Rs. Figure S1 . Surface expression and co-localization of hCB2-GFP and DiC16 in human SH-SY5Y cells. Details are given under Materials and Methods, and parameter values are summarized in Table S1 . (A and B) Double staining of SH-SY5Y cells expressing hCB2-GFP (A, a') with DiIC16 (B, b'), as a plasma membrane marker. Merged image of the magnified regions is shown in the panel a'/b'. For quantification of the overlap coefficient, the colocalization analysis of the two stainings was restricted to the region of interest which delimitates the plasma membrane (B and b'). For quantification of the membrane/total (M/T) ratio, the mean fluorescence (M and T) values of CB2 were calculated within the regions of interest, shown in A and B (and magnified in panels a' and b'). Images are representative of three independent experiments, for a total of 30 cells. (Scale bar: 10 µm)
